SetPoint Medical Appoints Anna Gawlicka as VP of Clinical Affairs
September 10, 2019 09:00 ET
|
SetPoint Medical
VALENCIA, Calif., Sept. 10, 2019 (GLOBE NEWSWIRE) -- SetPoint Medical, a clinical-stage company developing therapy for chronic autoimmune diseases, today announced the appointment of Anna Gawlicka,...
SetPoint Medical to Present Results From The U.S. Pilot Study in Rheumatoid Arthritis Patients at European Congress of Rheumatology (EULAR) 2019
June 03, 2019 13:26 ET
|
SetPoint Medical
VALENCIA, Calif., June 03, 2019 (GLOBE NEWSWIRE) -- SetPoint Medical, a clinical-stage bioelectronic medicine company developing therapy for chronic autoimmune diseases, today announced that results...
Global Autoinjectors Market is Set to Reach USD 4.5 Billion by 2024, Growing at a CAGR of 16.9% During the Forecast Period: VynZ Research
June 03, 2019 06:18 ET
|
VynZ Research
NEW YORK, June 03, 2019 (GLOBE NEWSWIRE) -- The global autoinjectors market is predicted to grow at 16.9% CAGR during the forecast period with the market size reaching USD 4.5 billion by 2024. The...
Trivedi Global, Inc. Announces Research by Dahryn Trivedi on the Impact of the Trivedi Effect to Reduce Rheumatoid Arthritis Related Inflammation
May 28, 2019 12:32 ET
|
Trivedi Global, Inc.
Las Vegas, Nevada, USA, May 28, 2019 (GLOBE NEWSWIRE) -- Dahryn Trivedi, an evidence-based healer, today released research results from preclinical research on the beneficial impact of biofield...
Exagen, Maker of AVISE Testing, Announces First Blood Test for Anti-CarP, a Breakthrough Bio-marker for Rheumatoid Arthritis
September 11, 2018 10:05 ET
|
Exagen Diagnostics, Inc.
San Diego, CA and Albuquerque, NM, Sept. 11, 2018 (GLOBE NEWSWIRE) -- Exagen Diagnostics, the leader in specialty rheumatology testing, announced today availability of the first validated blood test...
Autoimmune Disease Diagnostics Market worth over $16 Billion by 2024: Global Market Insights, Inc.
October 19, 2017 07:00 ET
|
Global Market Insights, Inc
Ocean View, Delaware, Oct. 19, 2017 (GLOBE NEWSWIRE) -- Autoimmune Disease Diagnostics Market is expected to cross USD 16 billion by 2024; according to a new research report by Global Market...
CrownBio Launches Innovative Inflammatory Disease Models to Advance Pre-Clinical Research
August 01, 2017 08:00 ET
|
Crown Bioscience
SANTA CLARA, Calif., Aug. 01, 2017 (GLOBE NEWSWIRE) -- Crown Bioscience, a wholly-owned subsidiary of Crown Bioscience International (TWSE: ticker 6554) and a global drug discovery and development...
Axsome Therapeutics Announces AXS-06 (MoSEIC™ Meloxicam and Esomeprazole) Meets Primary Endpoint in Phase 1 Clinical Trial
July 25, 2017 07:00 ET
|
Axsome Therapeutics, Inc.
AXS-06 is an oral, rapidly-absorbed, once-daily, non-opioid, COX-2 preferential pain therapeutic with a gastroprotectant Primary endpoint met with 9 times faster time to maximum plasma concentration...
Autoimmune Disease Diagnostics Market size worth USD 15 Billion by 2023: Global Market Insights Inc.
July 13, 2016 11:00 ET
|
Global Market Insights
Ocean View, Delaware, July 13, 2016 (GLOBE NEWSWIRE) -- Autoimmune Disease Diagnostics Market size is estimated to reach USD 15.7 billion by 2023; as per a new research report by Global Market...
Rheumatology Providers, FDA Leaders Discuss Biosimilar Policy Challenges and Opportunities at National Policy Briefing
June 20, 2016 18:41 ET
|
American College of Rheumatology
WASHINGTON, June 20, 2016 (GLOBE NEWSWIRE) -- Experts from the American College of Rheumatology (ACR), Food and Drug Administration (FDA), and other leading national healthcare groups spoke about the...